Generic Name: Rivaroxaban
Brand Name: Xarelto
Manufacturer: Bayer Inc.
Indications: Atrial fibrillation, stroke prevention
Submission Type: Pre-NOC
Project Status: Complete
Date Recommendation Issued: April 19, 2012
Recommendation Type: List with clinical criteria and/or conditions